|
|
BioMS Medical Corp (TSX MS)
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies with emphasis on the treatment of multiple sclerosis (MS). BioMS
Medical has obtained an exclusive worldwide license to a proprietary technology
developed at the MS Patient Care and Research Clinic at the University of
Alberta for the treatment of MS. The technology, MBP8298, is a synthetic myelin
basic protein peptide comprised of 17 amino acids which is intravenously
injected (every six months) into MS patients as a therapeutic treatment.
RECENT NEWS: CORRECTED - UPDATE - Lilly, BioMS scrap MS drug after trial fails
BioMS Medical announces second quarter 2009 results Douglas W. Loe Phd ...........Versant Partners…July 29, 2009 Downgraded to SELL from BUY Target reduced to 0.50 from $11.00 MS Price day before: $2.70 Finish day of posting:$0.40Current:$0.40C -----Dec 18, 2007------- Upgraded to BUY from SPECULATIVE BUY Target raised to $12.25 from $5.25 MS Price day before: $2.70 Finish day of posting:$3.72Current:$0.40C *************** Maher Yaghi ...........Desjardins Securities…July 29, 2009 Downgraded to SELL from HOLD Target reduced to 0.75 from $5.75 MS Price day before: $2.70 Finish day of posting:$0.40Current:$0.40C ------Jan 30, 2009----- Downgraded to HOLD from BUY Target $5.75 MS Price day before: $3.43 Finish day of posting:$2.39Current:$0.40C -------Dec 18, 2007---- Maintained BUY Target raised to $5.75 from $3.85 MS Price day before: $2.70 Finish day of posting:$3.72Current:$0.40C *************** Maria Luckevich ...........Research Capital…Dec 19, 2007 Maintained SPECULATIVE BUY Target raised to $10.00 from $6.00 MS Price day before: $3.72 Finish day of posting:$3.80Current:$0.40C *************** Stefan Quenneville ...........Macquarie Capital Markets…Dec 18, 2007 Maintained OUTPERFORM Target raised to $7.00 MS Price day before: $2.70 Finish day of posting:$3.72Current:$0.40C *************** Elmer Piros ...........Rodman Renshaw…Dec 18, 2007 Maintained OUTPERFORM Target raised to $9.00 from $6.00 MS Price day before: $2.70 Finish day of posting:$3.72Current:$0.40C ***************
|